MICHAEL BELLUCCI: Open Payments
NPI 1487438693 · RENO, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,370 in 54 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $1,033 · 2025 $1,370
Food & beverage: $1,370
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $452 |
| Phathom Pharmaceuticals, Inc. | 6 | $278 |
| Janssen Biotech, Inc. | 6 | $253 |
| Aimmune Therapeutics, Inc. | 4 | $168 |
| Madrigal Pharmaceuticals | 2 | $93 |
| GENZYME CORPORATION | 3 | $48 |
| QOL Medical, LLC | 2 | $44 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| Regeneron Healthcare Solutions, Inc. | 1 | $14 |
Products named: VOQUEZNA, TREMFYA, RINVOQ, ZENPEP, REZDIFFRA, SKYRIZI, DUPIXENT, CREON.
Industry payments across NV — which companies pay providers there.
